Sanjeej Jain

“First, on the CDMO business, this new capacity again will be entirely dedicated for the existing contract, and when you say we want to participate more in the supply chain, what does it really mean?”

“First, on the infrastructure space in the Dahaj, How much land more left because the Odisha plant may take another two years to come? For the next two years, do we have enough land parcel available in the Dahej facility for us to commission all the active ingredients we are working there?”

“On the other segment, the EBIT has fallen from 25 crore last quarter to around 1 crore this quarter. What has changed? Because revenue number hasn't changed much.”

“No, I am on handset, but hopefully you can hear me properly now. Hi, sir. Good morning. First on the suspension, PVC, can you help us understand now that things are settling down, how is the trend for the spread as we speak in the Q1?”

“Thank you for joining on for Tattwa Chintan Pharma Kevin Wittet Q4FI26 Results Conference Call. We have Tattwa Chintan Management on call, represented by Mr. Chintan Shah, Managing Director, Mr. Ajesh Pillai, Chief Financial Officer.”